Valuation Amarin Corporation plc

Stocks

Delayed Nasdaq 15:31:14 13/11/2026 GMT			5-day change	1st Jan Change
11.56 ^USD	-0.94%		-0.43%	-17.16%

11-09	Amarin Corporation plc Highlights New Clinical Data on Lipoprotein(A) and Apolipoprotein B Containing Lipoproteins At American Heart Association Scientific Sessions 2026	CI
11-06	European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,333	488.6	355.2	199.5	290.2	245.9	-	-
Change	-	-63.35%	-27.3%	-43.84%	45.45%	-15.25%	-	-
Enterprise Value (EV) ¹	1,114	270.4	156	78.46	155.5	77.46	59.01	42.06
Change	-	-75.72%	-42.33%	-49.69%	98.19%	-50.19%	-23.82%	-28.73%
P/E	169x	-4.65x	-5.8x	-2.43x	-155x	-	-	-
PBR	2x	0.82x	0.64x	0.41x	-	0.55x	0.55x	0.56x
PEG	-	0x	0.1x	-0.1x	1.6x	-	-	-
Capitalization / Revenue	2.29x	1.32x	1.16x	0.87x	1.36x	1.34x	1.3x	1.33x
EV / Revenue	1.91x	0.73x	0.51x	0.34x	0.73x	0.42x	0.31x	0.23x
EV / EBITDA	44.9x	-5.69x	-2.31x	-0.86x	-3.1x	-2.23x	-2.33x	-1.49x
EV / EBIT	46x	-3.64x	-2.31x	-0.85x	-3.1x	-2.23x	-2.33x	-1.49x
EV / FCF	-16.7x	-1.5x	22.7x	-2.53x	-	3.1x	4.54x	-
FCF Yield	-5.97%	-66.8%	4.41%	-39.5%	-	32.3%	22%	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.4	-5.2	-3	-4	-0.09	-	-	-
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	583.2	369.2	306.9	228.6	213.6	183.4	189	185.1
EBITDA ¹	24.81	-47.5	-67.43	-91.7	-50.17	-34.75	-25.35	-28.22
EBIT ¹	24.22	-74.26	-67.59	-91.8	-50.17	-34.75	-25.35	-28.22
Net income ¹	7.729	-105.8	-59.11	-82.18	-38.8	-23.57	-13.16	-17.36
Net Debt ¹	-219.5	-218.2	-199.3	-121	-134.7	-168.5	-186.9	-203.9
Reference price ²	67.40	24.20	17.40	9.70	13.96	11.67	11.67	11.67
Nbr of stocks (in thousands)	19,781	20,191	20,415	20,567	20,793	21,073	-	-
Announcement Date	01/03/22	01/03/23	29/02/24	12/03/25	25/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
AMARIN CORPORATION PLC	-	0.42x	-2.23x	-	246M
WUXI APPTEC CO., LTD.	17.83x	6.87x	13.17x	1.67%	68.45B
ARGENX SE	33.16x	8.87x	29.33x	0.07%	61.31B
LONZA GROUP AG	38.6x	6.87x	20.53x	0.84%	55.73B
BEONE MEDICINES AG	44.64x	6.26x	29.95x	-.--%	47.51B
IQVIA HOLDINGS INC.	35.38x	3.35x	14.45x	-.--%	44.68B
REVOLUTION MEDICINES, INC.	-21.05x	55.83x	-23.07x	-.--%	38.14B
CELLTRION, INC.	35.39x	8.76x	22.85x	0.37%	35.85B
GENMAB A/S	41.18x	8.09x	26.85x	-.--%	33.05B
INSMED INCORPORATED	-72.05x	13.64x	-73.33x	-.--%	25.9B
Average	17.01x	11.90x	5.85x	0.33%	41B
Weighted average by Cap.	22.08x	11.95x	11.78x	0.44%